Proteomic alterations in the cerebellum and hippocampus in an Alzheimer?s disease mouse model: Alleviating effect of palmatine

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKiris, Irem
dc.contributor.authorKukula\\-Koch, Wirginia
dc.contributor.authorKarayel\\-Basar, Merve
dc.contributor.authorGurel, Busra
dc.contributor.authorCoskun, Julide
dc.contributor.authorBaykal, Ahmet Tarik
dc.date.accessioned2025-10-16T15:16:26Z
dc.date.issued2023
dc.identifier.doi10.1016/j.biopha.2022.114111
dc.identifier.otherWOS:000904404200002
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6700
dc.publisherELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
dc.sourceBIOMEDICINE \& PHARMACOTHERAPY
dc.subjectAlzheimer\\?s Disease
dc.subject5xFAD
dc.subjectPalmatine
dc.subjectNeurodegeneration
dc.subjectLabel \\-free Proteomics
dc.titleProteomic alterations in the cerebellum and hippocampus in an Alzheimer?s disease mouse model: Alleviating effect of palmatine
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS